top of page

Smarter Commercialization
Faster Results

Expert-led strategy and AI insights to cut time-to-market and reduce risk by up to 60%

Fractional 
Leadership
Deep Domain
Expertise
De-risk Commercialization
up to 60% 

 
Clarity AI HITL Commercial Workflow 
Experienced Leadership
Team

Smarter Commercialization with Lower Risk

We help life sciences, healthcare, and health AI companies go to market faster, smarter, and with less risk by combining expert-led commercialization strategy, AI-powered insights, and integrated execution to out perform industry benchmarks in speed, ROI, and success rate.
 
The Healthcare Innovation Challenge

​​

The healthcare industry faces unprecedented challenges in bringing innovative products to market. With 90% of startups failing overall and 98% of digital health startups encountering significant challenges, the stakes have never been higher. Healthcare companies specifically face an 80% failure rate, while 75% of medical device startups never find success. The average cost to bring a Class II medical device to market exceeds $31 million, with 77% of costs related to regulatory activities.

 

Time to Market: Where Speed Matters Most
​

Time to market represents the most critical competitive advantage in healthcare commercialization. 56% of medical device companies identify time-to-market reduction as their top priority, with organizations targeting an average 25% reduction in development time to remain competitive.

Strategic Growth AI Time to market

Time to Market Comparison: Strategic Growth AI vs Industry Standards

 

Our analysis reveals that Strategic Growth AI delivers 40-44% faster time-to-market across all device categories compared to industry averages. This translates to bringing a Class III device to market in 4 years instead of 7, and AI-enabled devices in 2.8 years versus 5 years.

​

ROI Performance: Measurable Financial Returns

Return on investment remains the ultimate measure of consulting effectiveness. Healthcare organizations demand tangible financial results, not just advisory services.

StrategicGrowthAI information on ROI Time by Provider

ROI Performance Comparison: Strategic Growth AI Delivers Superior Returns

​

Strategic Growth AI delivers 3.5x ROI compared to 1.5x for in-house development, achieving returns in 14 months versus 36 months for traditional approaches. Our 85% success rate significantly outperforms the 45% success rate of in-house development teams.

​

Success Rates: Beating Industry Failure Statistics

The healthcare startup landscape is littered with failures, but Strategic Growth AI clients consistently outperform industry benchmarks.

StrategicGrowthAI information on start up success rate

Healthcare Startup Success: StrategicGrowthAI Clients Outperform Industry Averages

 

While 98% of digital health startups fail and 75% of MedTech startups never succeed, Strategic Growth AI clients achieve 88-95% success rates across all healthcare categories. Our 92% success rate for healthcare startups dramatically outperforms the industry's 20% survival rate.

 

Market Growth: Positioning for AI Healthcare Expansion

The AI healthcare market represents unprecedented growth opportunities, expanding from $26.69 billion in 2024 to $187.69 billion by 2030 at a 36.83% CAGR.

StrategicGrowthAI information on AI Healthcare market

AI Healthcare Market: Explosive Growth Through 2030

 

This explosive growth creates massive opportunities for companies with proper AI integration and commercialization strategies. StrategicGrowthAI's AI-powered methodologies position clients to capture market share in this expanding sector.

​

Cost Efficiency: Delivering More with Less

Healthcare development costs continue to escalate, with complex medical device development averaging $522 million[when accounting for failures and capital costs. Strategic Growth AI delivers significant cost reductions across all development phases.

StrategicGrowthAI information on Health company cost breakdown

Development Cost Savings: Strategic Growth AI Delivers 25-42% Cost Reduction

 

Our proprietary methodologies achieve 25-42% cost savings across all development categories, with the highest savings in Market Access (42%) and Regulatory Affairs (38%). These savings directly translate to improved profitability and reduced financial risk.

​

Pain Points Resolution: Systematic Problem Solving
​

Healthcare companies face five critical pain points that threaten commercialization success. Strategic Growth AI's integrated approach addresses each systematically.

StrategicGrowthAI information on Health company Pain Points

Pain Points Analysis: Strategic Growth AI Solutions Outperform Industry Standards

 

Our solutions deliver 8-27% improvement over industry standards, with the most significant gains in Commercial Readiness (27% improvement) and Technical Risk mitigation (24% improvement). This comprehensive approach ensures sustainable success rather than point solutions.

 

Why Strategic Growth AI Outperforms Competitors

 

  • Speed and Agility​

  • Predictable Outcomes

  • ​Superior ROI

  • Comprehensive Integration

  • Proven Track Record

  • AI-Powered Insights

​​

Professional Networks

UBC Entrepreneurship   • BC Tech   • AIinBC   • Life Sciences BC

bottom of page